Not to be Johnny Raincloud...but a lot of our prescription drug manufacturing got out-sourced...China I believe is where we get pretty much get all of our antibiotics from...
Updated for late to the party ass-head -
https://www.washingtonexaminer.com/news/we-gave-away-these-industries-marco-rubio-warns-of-risk-posed-by-china-nearly-controlling-antibiotics-market
Sure, now you're worried.
Dick!
I think I posted this before. 97% of anti biotics in US are imported. China low balled antibiotic prices and all US fermentation plants were shut down.
I went to Walmart to pick up some pills. Irbesartan is a high BP med.
This was a $24 per 90 day med cost. I had to pay $211.
So, there is a shortage. Some precursor contained a small amount of a carcinogen.
Maybe the FDA over reacted. I am not sure how much of the precursor was made in China. Maybe I did not dig hard enough. The big pharma companies want you to think it does not matter where it is made.
google "irbesartan' and you will see all the autocomplete suggestions about recalls. Also many other drugs using the same precursors?
...
https://theconservativetreehouse.com/2020/02/10/peter-navarro-coronavirus-highlights-need-for-u-s-to-make-our-own-medical-products-again/Peter Navarro: Coronavirus Highlights Need for U.S. to Make Our Own Medical Products Again…
Posted on February 10, 2020 by sundance
White House manufacturing policy advisor Peter Navarro has an important discussion with Maria Bartiromo about the consequences of the Coronavirus which includes the need for U.S. companies to return manufacturing to the United States on key
medical products and pharmaceuticals. A very important subject.
Both Navarro and Bartiromo note that our dependency on Asia for medical products is a problem when a global virus erupts, global demand for those products peaks, and the supply of those products becomes most urgent.
...
https://youtu.be/uiNcasUBqWAhttps://www.usatoday.com/story/news/health/2019/01/18/prinston-pharmaceuticals-recall-irbesartan-blood-pressure-medicines-fda-valsartan-losartan/2618695002/...
Prinston Pharmaceuticals recalled one lot of irbesartan tablets and seven lots of irbesartan HCTZ tablets. The medication contained unacceptable levels of the probable carcinogen nitrosodiethylamine, or NDEA, the company said.
The drugs ingredients were made by Zhejiang Huahai Pharmaceuticals, a factory in China that has been linked to several recalls of commonly prescribed blood pressure drugs since July. The Food and Drug Administration has issued a warning letter and halted all new drug shipments from Zhejiang Huahai since uncovering a series of problems at the factory.
...